Quantum-Si Incorporated Stock Price, News & Analysis

Quantum-Si (QSI) has announced the granting of 44,893 restricted stock units (RSUs) to new employees through its 2023 Inducement Equity Incentive Plan. The grants, approved by the Compensation Committee of QSI's Board of Directors, serve as inducement material for new hires in accordance with Nasdaq Listing Rule 5635(c)(4).

The RSUs will follow a vesting schedule where 25% will vest on March 20, 2026, with the remaining portion vesting in 12 equal quarterly installments thereafter. Vesting is contingent upon continued employment with the company. These equity awards are exclusively granted to individuals who were not previously QSI employees, as part of their employment compensation package.

Quantum-Si (Nasdaq: QSI) launches Platinum® Pro, a new benchtop sequencer aimed at revolutionizing protein analysis in proteomics research. The system is now available for ordering and features a comprehensive, integrated workflow designed to simplify complex protein sequencing.

Key innovations include an enlarged touchscreen with an elegant user interface, flexible data analysis options (local and cloud-based), and a Pro Mode for custom application development through a Technology Access Program. The product is intended to democratize access to proteomics, providing tools for diverse applications from proteoform analysis to protein barcoding.

CEO Jeff Hawkins emphasizes Platinum Pro's role in making proteomics more accessible, while Chief Commercial Officer Todd Bennett highlights a new partnership with Avantor, which will expand the product's availability in the U.S. and Canada. The system is expected to drive new opportunities for breakthrough discoveries and will begin shipping in the first quarter.

For more information or to place an order, visit Quantum-Si's website.

Quantum-Si (Nasdaq: QSI) has released a new preprint demonstrating the integration of their benchtop Platinum® instrument with protein barcoding technology. The study showcases a novel workflow that enhances multiplexed protein analysis with improved sensitivity and accessibility compared to traditional methods like mass spectrometry.

The research validated eight peptide barcodes designed for minimal detection bias and maximum sensitivity, featuring a streamlined workflow that reduces sample input requirements and hands-on time to under one hour. The system demonstrated a ten-fold dynamic range for detecting low-abundance proteins.

The combination of QSI's Platinum® Pro instrument with their protein Barcoding Kit offers advantages over DNA barcodes by providing direct quantitative readout of protein expression and localization. This advancement has potential applications in protein engineering, targeted drug delivery, and nucleic acid therapy development.

Quantum-Si (QSI) has announced a registered direct offering of 15,625,000 shares of common stock priced at $3.20 per share, aiming to raise approximately $50 million in gross proceeds. The offering is expected to close around January 6, 2025, subject to customary closing conditions.

The company plans to use the net proceeds for working capital and general corporate purposes. A.G.P./Alliance Global Partners is serving as the sole placement agent for this offering, which is being conducted under an effective shelf registration statement on Form S-3 that was declared effective by the SEC on August 22, 2023.

Quantum-Si (QSI) announced a new preprint demonstrating its proprietary bioinformatics tool ProteoVue, designed for detecting and quantifying Single Amino Acid Variants (SAAVs). The tool is part of the Platinum Analysis Software for the company's Platinum benchtop instrument. ProteoVue enables detection of protein variations, quantification of post-translational modifications, and characterization of proteins with unnatural amino acids.

The software leverages advanced signal processing, neural network-driven kinetic signature modeling, and clustering framework to provide insights into protein variants, including those undetectable by mass spectrometry. This development aligns with QSI's recent collaboration with NVIDIA to enhance sequencing performance through AI and follows the announcement of their next-generation platform, Proteus.

Quantum-Si (QSI) has announced that its Board's Compensation Committee has granted 46,666 restricted stock units (RSUs) to new employees under the company's 2023 Inducement Equity Incentive Plan. The RSUs were granted as an inducement for new employees joining the company, in compliance with Nasdaq Listing Rule 5635(c)(4). The vesting schedule includes 25% vesting on December 20, 2025, followed by the remaining amount vesting in 12 equal quarterly installments, contingent on continued employment.

Quantum-Si (Nasdaq: QSI) has announced a significant expansion of its international distribution network, now totaling 15 partners. The expansion covers multiple regions including Western and Eastern Europe, Asia, Middle East, Africa, South America, and the South Pacific. This strategic move, combined with the recently announced Avantor distribution agreement for North America, aims to accelerate the global adoption of their Platinum® product and drive revenue growth from 2025 onwards. The company is focusing on broadening access to research customers globally through these partnerships.

Canada Nickel reported positive assay results from drill hole BAN24-20 at its Bannockburn property, located 65 kilometers south of Timmins. The hole intersected 1.11% nickel over 10.1 metres, including 1.32% nickel, 0.17% copper, and 0.55 g/t palladium + platinum over 4.4 metres.

This mineralized interval is situated 138 metres northwest of BAN24-18, which previously intersected 1.61% nickel over 12.0 metres. The company has completed a new BHEM survey in BAN24-20 to test the continuation of high-grade horizons, revealing two separate lenses of mineralization. Follow-up drilling is currently in progress with hole BAN24-21.

Quantum-Si (Nasdaq: QSI) has launched the Platinum Library Prep Kit, V2, an advanced tool for single-molecule protein sequencing. The new kit offers significant improvements in accessibility and efficiency, reducing hands-on preparation time to under two hours while maintaining precision. Key features include:

- 85% success rate in generating libraries and sequencing results
- Requires fivefold less protein input than V1
- Compatible with standard lab equipment
- Optimized for various protein conditions

The innovation aims to make Next-Gen Protein Sequencing™ more accessible to research labs using QSI's benchtop instrument.